Incorporating the assessment of abuse liability into the drug discovery and development process
- 2 May 2003
- journal article
- review article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 70 (3) , S73-S85
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Conditioned place preference: what does it add to our preclinical understanding of drug reward?Psychopharmacology, 2000
- Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABA A -ergic ligandsPsychopharmacology, 2000
- A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United StatesDrug and Alcohol Dependence, 1999
- Drug Discrimination in NeurobiologyPharmacology Biochemistry and Behavior, 1999
- Abuse Potential of Dronabinol (Marinol®)Journal of Psychoactive Drugs, 1998
- Physicians' Decisions to Prescribe Benzodiazepines for Nervousness and InsomniaJournal of General Internal Medicine, 1997
- The intravenous self-administration of antihistamines by rhesus monkeysDrug and Alcohol Dependence, 1992
- Stimulus functions of drugs and the assessment of abuse liabilityDrug Development Research, 1990
- Experimental analysis of the ?happy hour?: Effects of purchase price on alcohol consumptionPsychopharmacology, 1978
- Effects of response requirement upon human sedative self-administration and drug-seeking behaviorPharmacology Biochemistry and Behavior, 1976